Anti-HBs level ≥ 10 IU/L | Anti-HBs level ≥ 100 IU/L | |||
---|---|---|---|---|
OR | 95% CI | OR | 95% CI | |
Model 1 (Recommended schedule (≥ 3 doses)) | ||||
Recommended schedule (≥ 3 doses) | ||||
Yes | 0.92 | 0.65–1.32 | 1.16 | 0.79–1.70 |
No | Reference | Reference | ||
Time since last vaccination dose (in years) | 0.85 | 0.82–0.88 | 0.83 | 0.79–0.86 |
Type of vaccine | ||||
Infanrix Hexa | Reference | Reference | ||
Hexavac | 0.44 | 0.30–0.64 | 0.38 | 0.21–0.72 |
Monovalent | 1.38 | 0.98–1.96 | 2.06 | 1.42–2.99 |
Model 2; 3 versus 4 doses (Recommended schedule (≥ 3 doses)) | ||||
3 versus 4 doses | ||||
3 doses | Reference | Reference | ||
4 doses | 1.44 | 0.81–2.60 | 1.06 | 0.60–1.85 |
Time since last vaccination dose (in years) | 0.85 | 0.82–0.89 | 0.83 | 0.79–0.86 |
Type of vaccine | ||||
Infanrix Hexa | Reference | Reference | ||
Hexavac | 0.47 | 0.31–0.69 | 0.42 | 0.20–0.85 |
Monovalent | 1.95 | 1.06–3.57 | 2.11 | 1.23–3.63 |